US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alumis Inc.

3.02

-0.2800-8.48%

Post-market: 3.070.0500+1.66%17:51 EDT

Volume:1.75M

Turnover:5.33M

Market Cap:164.30M

PE:-0.36

High:3.30

Open:3.30

Low:2.98

Close:3.30

Loading ...

Overview Company News Filings

Alumis Price Target Announced at $18.00/Share by Guggenheim

Analysts Are Bullish on These Materials Stocks: Westlake Corporation (WLK), Alumis Inc. (ALMS)

Alumis resumed with an Overweight at Morgan Stanley

Alumis Completes Enrollment of Pivotal Phase 3 Onward Clinical Program of Lead Candidate Esk-001, a Highly Selective, Next-Generation Oral Tyk2 Inhibitor for the Treatment of Moderate-to-Severe Plaque Psoriasis

THOMSON REUTERS

Alumis Inc. Files Initial Statement of Beneficial Ownership for Director Lynn A. Tetrault

H.C. Wainwright Remains a Buy on Alumis Inc. (ALMS)

Alumis, Acelyrin Close Merger

MT Newswires Live

Alumis Inc. Completes Merger with ACELYRIN, Inc.

ACELYRIN Completes Merger and Delists from Nasdaq

Alumis Inc. Completes Merger with ACELYRIN, Strengthening Late-Stage Biopharma Portfolio

Alumis completes merger with Acelyrin

Alumis Completes Merger With ACELYRIN

THOMSON REUTERS

Alumis Inc - CEO States Merger Extends Cash Runway Into 2027

THOMSON REUTERS

Alumis Inc. Stockholders Approve Merger with ACELYRIN

Alumis Inc. Conducted Virtual Special Stockholder Meeting

Alumis Inc. Reports Q1 2025 Financial Results and Strategic Progress

Oppenheimer Trims Price Target on Alumis to $25 From $26, Keeps Outperform Rating

MT Newswires Live

Alumis Q1 Sales $17.39M

Alumis Inc. Stockholders Approve Merger with ACELYRIN, Anticipating Successful Close in Q2 2025

Press Release: Alumis Reports First Quarter 2025 Financial Results and Highlights Recent Achievements

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ALMS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALMS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMS\",,,,,undefined,":{"symbol":"ALMS","market":"US","secType":"STK","nameCN":"Alumis Inc.","latestPrice":3.02,"timestamp":1751054400000,"preClose":3.3,"halted":0,"volume":1749137,"hourTrading":{"tag":"盘后","latestPrice":3.07,"preClose":3.02,"latestTime":"17:51 EDT","volume":249620,"amount":753913.7593,"timestamp":1751061115257},"delay":0,"floatShares":8664240,"shares":54405544,"eps":-8.309579,"marketStatus":"Not Yet Opened","change":-0.28,"latestTime":"06-27 16:00:00 EDT","open":3.3,"high":3.3,"low":2.98,"amount":5328272.554028,"amplitude":0.09697,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-8.309579,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1751270400000},"marketStatusCode":0,"adr":0,"listingDate":1719547200000,"exchange":"NASDAQ","adjPreClose":3.3,"preHourTrading":{"tag":"盘前","latestPrice":3.24,"preClose":3.3,"latestTime":"09:25 EDT","volume":9631,"amount":31356.201446,"timestamp":1751030700060},"postHourTrading":{"tag":"盘后","latestPrice":3.07,"preClose":3.02,"latestTime":"17:51 EDT","volume":249620,"amount":753913.7593,"timestamp":1751061115257},"volumeRatio":1.5611317833850968,"impliedVol":2.4275,"impliedVolPercentile":0.6909},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMS\",,,,,undefined,":{"symbol":"ALMS","floatShares":8664240,"roa":"-101.07%","roe":"-247.05%","lyrEps":-10.381567,"volumeRatio":1.5611317833850968,"shares":54405544,"dividePrice":0,"high":3.3,"amplitude":0.09697,"preClose":3.3,"low":2.98,"week52Low":2.7601,"pbRate":"0.98","psRate":"9.45","week52High":13.53,"institutionHeld":0,"latestPrice":3.02,"eps":-8.309579,"divideRate":0,"volume":1749137,"delay":0,"ttmEps":-8.309579,"open":3.3,"prevYearClose":7.86,"prevWeekClose":2.86,"prevMonthClose":3.5,"prevQuarterClose":6.14,"fiveDayClose":2.86,"twentyDayClose":3.91,"sixtyDayClose":7.24},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALMS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2542830345","title":"Alumis Price Target Announced at $18.00/Share by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2542830345","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542830345?lang=en_us&edition=fundamental","pubTime":"2025-06-10 23:02","pubTimestamp":1749567720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALMS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 10, 2025 11:02 ET (15:02 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS"],"gpt_icon":0},{"id":"2540729195","title":"Analysts Are Bullish on These Materials Stocks: Westlake Corporation (WLK), Alumis Inc. (ALMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2540729195","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540729195?lang=en_us&edition=fundamental","pubTime":"2025-06-03 16:30","pubTimestamp":1748939420,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Materials sector as 2 analysts just weighed in on Westlake Corporation (WLK – Research Report) and Alum...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-materials-stocks-westlake-corporation-wlk-alumis-inc-alms-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-materials-stocks-westlake-corporation-wlk-alumis-inc-alms-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARKG","BK4585","BK4090","BK4007","BK4588","BK4544","ALMS","WLK"],"gpt_icon":0},{"id":"2540324753","title":"Alumis resumed with an Overweight at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2540324753","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540324753?lang=en_us&edition=fundamental","pubTime":"2025-06-02 07:30","pubTimestamp":1748820604,"startTime":"0","endTime":"0","summary":"Morgan Stanley resumed coverage of Alumis (ALMS) with an Overweight rating and $23 price target The firm updated its model for the Acelyrin merger ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alumis-resumed-with-an-overweight-at-morgan-stanley-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alumis-resumed-with-an-overweight-at-morgan-stanley-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMS"],"gpt_icon":0},{"id":"2539571382","title":"Alumis Completes Enrollment of Pivotal Phase 3 Onward Clinical Program of Lead Candidate Esk-001, a Highly Selective, Next-Generation Oral Tyk2 Inhibitor for the Treatment of Moderate-to-Severe Plaque Psoriasis","url":"https://stock-news.laohu8.com/highlight/detail?id=2539571382","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539571382?lang=en_us&edition=fundamental","pubTime":"2025-05-29 19:55","pubTimestamp":1748519700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nTUA7KM2T6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2537154103","title":"Alumis Inc. Files Initial Statement of Beneficial Ownership for Director Lynn A. Tetrault","url":"https://stock-news.laohu8.com/highlight/detail?id=2537154103","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537154103?lang=en_us&edition=fundamental","pubTime":"2025-05-24 04:03","pubTimestamp":1748030639,"startTime":"0","endTime":"0","summary":"Alumis Inc. has filed an initial statement of beneficial ownership. The filing names Lynn A. Tetrault as the beneficial owner, who serves as a Director of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alumis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 23, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nNDL58LCY7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2537138679","title":"H.C. Wainwright Remains a Buy on Alumis Inc. (ALMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2537138679","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537138679?lang=en_us&edition=fundamental","pubTime":"2025-05-23 18:39","pubTimestamp":1747996779,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Mitchell Kapoor reiterated a Buy rating on Alumis Inc. (ALMS – Research Report) today and set a price target of $14.00. The...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-alumis-inc-alms?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-alumis-inc-alms?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2537939084","title":"Alumis, Acelyrin Close Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2537939084","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537939084?lang=en_us&edition=fundamental","pubTime":"2025-05-21 22:14","pubTimestamp":1747836871,"startTime":"0","endTime":"0","summary":"Alumis  said Wednesday that it has completed its merger with Acelyrin .Each Acelyrin shareholder will receive 0.4814 Alumis share for each Acelyrin share owned. Acelyrin shares have ceased trading on Nasdaq.\"This merger allows us to advance our pipeline through multiple planned key data readouts, with a cash runway that now extends into 2027,\" Alumis Chairman, CEO and President Martin Babler, said.Alumis shares were up over 8% in recent trading.Price: 5.28, Change: +0.40, Percent Change: +8.20","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALMS","BK4007","SLRN","BK4139"],"gpt_icon":0},{"id":"2537493914","title":"Alumis Inc. Completes Merger with ACELYRIN, Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2537493914","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537493914?lang=en_us&edition=fundamental","pubTime":"2025-05-21 21:50","pubTimestamp":1747835432,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Alumis Inc. ( ($ALMS) ). On May 21, 2025, Alumis Inc. completed its merger with ACELYRIN, Inc., creating a lead...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alumis-inc-completes-merger-with-acelyrin-inc?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alumis-inc-completes-merger-with-acelyrin-inc?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2537156939","title":"ACELYRIN Completes Merger and Delists from Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2537156939","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537156939?lang=en_us&edition=fundamental","pubTime":"2025-05-21 21:48","pubTimestamp":1747835332,"startTime":"0","endTime":"0","summary":"ACELYRIN, INC. ( ($SLRN) ) has shared an announcement. On May 21, 2025, ACELYRIN, Inc. completed a merger with Alumis, becoming a wholly owned subs...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/acelyrin-completes-merger-and-delists-from-nasdaq?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/acelyrin-completes-merger-and-delists-from-nasdaq?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NDAQ","USAW.SI","IE00B3QW5Z07.USD","USJW.SI","QLD",".IXIC","MNQmain","PSQ","LU2210149790.SGD","SQQQ","TSYW.SI","QID","LU2095319765.USD","BK4112","IE00B64PRP62.GBP","NVIW.SI","ALMS","NQmain","IE00BKPKM429.USD","BK4588","IE00BGHQF748.EUR","BK4585","LU2210150020.SGD","TQQQ","BK4007"],"gpt_icon":0},{"id":"2537359599","title":"Alumis Inc. Completes Merger with ACELYRIN, Strengthening Late-Stage Biopharma Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2537359599","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537359599?lang=en_us&edition=fundamental","pubTime":"2025-05-21 21:16","pubTimestamp":1747833390,"startTime":"0","endTime":"0","summary":"Alumis Inc., a late-stage biopharma company specializing in next-generation targeted therapies for immune-mediated diseases, has successfully completed its merger with ACELYRIN, Inc. This strategic move establishes a leading clinical-stage biopharma company with a robust portfolio and a strong financial position. As part of the merger, ACELYRIN stockholders will receive 0.4814 shares of Alumis common stock for each ACELYRIN share they own. With this merger, Alumis aims to advance its pipeline and extend its cash runway into 2027, ensuring continued development of transformative therapies for patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alumis Inc. published the original content used to generate this news brief via EDGAR, th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDL1Tk9ws:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","SLRN","BK4007","BK4139"],"gpt_icon":0},{"id":"2537352379","title":"Alumis completes merger with Acelyrin","url":"https://stock-news.laohu8.com/highlight/detail?id=2537352379","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537352379?lang=en_us&edition=fundamental","pubTime":"2025-05-21 21:15","pubTimestamp":1747833326,"startTime":"0","endTime":"0","summary":"Alumis (ALMS) has completed its merger with ACELYRIN (SLRN). Each ACELYRIN stockholder will receive 0.4814 shares of Alumis common stock for each s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alumis-completes-merger-with-acelyrin?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alumis-completes-merger-with-acelyrin?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLRN","BK4139","ALMS","BK4007"],"gpt_icon":0},{"id":"2537993553","title":"Alumis Completes Merger With ACELYRIN","url":"https://stock-news.laohu8.com/highlight/detail?id=2537993553","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537993553?lang=en_us&edition=fundamental","pubTime":"2025-05-21 21:10","pubTimestamp":1747833051,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nTUA5CPJTY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2537935535","title":"Alumis Inc - CEO States Merger Extends Cash Runway Into 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2537935535","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537935535?lang=en_us&edition=fundamental","pubTime":"2025-05-21 21:10","pubTimestamp":1747833051,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nTUA5CPJTY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALMS","BK4139","SLRN","BK4007"],"gpt_icon":0},{"id":"2536630693","title":"Alumis Inc. Stockholders Approve Merger with ACELYRIN","url":"https://stock-news.laohu8.com/highlight/detail?id=2536630693","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536630693?lang=en_us&edition=fundamental","pubTime":"2025-05-20 04:36","pubTimestamp":1747686982,"startTime":"0","endTime":"0","summary":"Alumis Inc. ( ($ALMS) ) has shared an update. On May 13, 2025, Alumis Inc. held a virtual special meeting where stockholders voted on proposals rel...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alumis-inc-stockholders-approve-merger-with-acelyrin?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alumis-inc-stockholders-approve-merger-with-acelyrin?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2536637627","title":"Alumis Inc. Conducted Virtual Special Stockholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2536637627","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536637627?lang=en_us&edition=fundamental","pubTime":"2025-05-20 04:06","pubTimestamp":1747685167,"startTime":"0","endTime":"0","summary":"Alumis Inc. held a virtual special meeting of its stockholders on May 13, 2025. During the meeting, stockholders voted on two key proposals. The proposal to approve the issuance of shares of Common Stock to stockholders of ACELYRIN in connection with the merger was approved. Additionally, the proposal to approve the adjournment from time to time of the Special Meeting, if necessary, to solicit additional proxies was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alumis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 19, 2025, and is solely responsible for the infor","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nNDLbbNDpx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007","SLRN","BK4139"],"gpt_icon":0},{"id":"2535339777","title":"Alumis Inc. Reports Q1 2025 Financial Results and Strategic Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2535339777","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535339777?lang=en_us&edition=fundamental","pubTime":"2025-05-16 12:36","pubTimestamp":1747370176,"startTime":"0","endTime":"0","summary":"Alumis Inc. ( ($ALMS) ) has released its Q1 earnings. Here is a breakdown of the information Alumis Inc. presented to its investors. Alumis Inc. is...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alumis-inc-reports-q1-2025-financial-results-and-strategic-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alumis-inc-reports-q1-2025-financial-results-and-strategic-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS","BK4097","ALMS","BK4007","LU2065732104.USD"],"gpt_icon":0},{"id":"2535540847","title":"Oppenheimer Trims Price Target on Alumis to $25 From $26, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2535540847","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535540847?lang=en_us&edition=fundamental","pubTime":"2025-05-15 20:23","pubTimestamp":1747311827,"startTime":"0","endTime":"0","summary":"Alumis (ALMS) has an average rating of buy and mean price target of $21.25, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OPY","ALMS"],"gpt_icon":0},{"id":"2535585000","title":"Alumis Q1 Sales $17.39M","url":"https://stock-news.laohu8.com/highlight/detail?id=2535585000","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535585000?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:29","pubTimestamp":1747254561,"startTime":"0","endTime":"0","summary":"Alumis (NASDAQ:ALMS) reported $17.39 million in sales this quarter.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45421234/alumis-q1-sales-17-39m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS"],"gpt_icon":0},{"id":"2535072450","title":"Alumis Inc. Stockholders Approve Merger with ACELYRIN, Anticipating Successful Close in Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2535072450","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535072450?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:22","pubTimestamp":1747254138,"startTime":"0","endTime":"0","summary":"Alumis Inc., a clinical-stage biopharmaceutical company, announced an update on its merger agreement with ACELYRIN, Inc. On May 13, 2025, Alumis stockholders approved all proposals related to the pending merger during a Special Meeting of Stockholders. The merger, slated for completion in the second quarter of 2025, aims to enhance value creation opportunities for both companies' stockholders. The amended agreement stipulates that ACELYRIN stockholders will receive 0.4814 shares of Alumis common stock per ACELYRIN share. Post-merger, Alumis stockholders will hold approximately 52% of the combined entity, while ACELYRIN stockholders will own around 48% on a fully diluted basis. The merger is expected to advance a differentiated clinical pipeline and provide financial flexibility for strategic opportunities in immune-mediated diseases.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDL277fdN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","SLRN","ALMS"],"gpt_icon":0},{"id":"2535020710","title":"Press Release: Alumis Reports First Quarter 2025 Financial Results and Highlights Recent Achievements","url":"https://stock-news.laohu8.com/highlight/detail?id=2535020710","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535020710?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:05","pubTimestamp":1747253100,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., May 14, 2025  -- Alumis Inc. , a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients with immune-mediated diseases, today reported financial results for the quarter ended March 31, 2025, and highlighted recent achievements and upcoming milestones.Babler continued, \"We are also focused on the anticipated close of the merger with ACELYRIN in the second quarter of this year. We continue to believe that the merger will support the advancement of a differentiated clinical pipeline combined with enhanced financial flexibility to enable strategic opportunities across a broad range of immune-mediated diseases, creating value for patients and stockholders.\"","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089283258.USD","BK4516","LU0225283273.USD","LU0006306889.USD","LU0912757837.SGD","LU1668664300.SGD","LU1720051017.SGD","IE00BZ1G4Q59.USD","LU0320765646.SGD","LU0795875169.SGD","IE00BKVL7J92.USD","LU1162221912.USD","LU0267386448.USD","LU2347655156.SGD","BK4588","LU2271345857.HKD","BK4534","LU1074936037.SGD","LU1989772923.USD","LU0106261372.USD","LU1548497426.USD","LU0158827948.USD","LU0314104364.USD","LU1363072403.SGD","LU0795875086.SGD","BK4007","LU0098860793.USD","LU1720051108.HKD","BK4585","LU1732800096.USD","LU1732799900.SGD","LU0158827781.USD","ALMS","BK4581","LU2089284900.SGD","LU2133065610.SGD","LU2111349929.HKD","LU0971096721.USD","LU1989772840.SGD","LU2023251221.USD","BK4127","BK4504","LU2357305700.SGD","LU2028103732.USD","LU0106831901.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":112,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALMS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-14","symbol":"ALMS","fiscalQuarterEnding":"2025/03","expectedEps":-1.47,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-1.82},{"market":"US","date":"2025-03-19","symbol":"ALMS","fiscalQuarterEnding":"2024/12","expectedEps":-1.39,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742356800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-13","symbol":"ALMS","fiscalQuarterEnding":"2024/09","expectedEps":-1.64,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-1.73}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALMS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALMS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":6,"updateTime":1749614400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALMS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALMS","date":"2025-06-27","current":-0.522906,"percent":0.956175,"low":-4.913756,"twenty":-3.464493,"median":-1.909477,"eighty":-0.920124,"high":-0.443678,"avg":-2.15659,"sd":1.218803,"marketCap":179538295},"quantilePoints":[{"date":"2024-06-28","current":-4.084559,"twenty":-4.913756,"median":-4.913756,"eighty":-4.416238,"marketCap":689534895},{"date":"2024-07-05","current":-3.516406,"twenty":-4.747917,"median":-3.851156,"eighty":-3.59564,"marketCap":593622147},{"date":"2024-07-12","current":-3.405847,"twenty":-4.063676,"median":-3.825051,"eighty":-3.58397,"marketCap":574958044},{"date":"2024-07-19","current":-4.023985,"twenty":-4.026561,"median":-3.851156,"eighty":-3.52869,"marketCap":679309112},{"date":"2024-07-26","current":-4.023985,"twenty":-4.117224,"median":-3.947896,"eighty":-3.58397,"marketCap":679309112},{"date":"2024-08-02","current":-4.178507,"twenty":-4.123137,"median":-3.980142,"eighty":-3.620209,"marketCap":705394582},{"date":"2024-08-09","current":-3.850149,"twenty":-4.108328,"median":-3.938677,"eighty":-3.693301,"marketCap":649962958},{"date":"2024-08-16","current":-3.683794,"twenty":-4.085032,"median":-3.914533,"eighty":-3.659692,"marketCap":696362265},{"date":"2024-08-23","current":-3.672282,"twenty":-4.078883,"median":-3.855481,"eighty":-3.667968,"marketCap":694186133},{"date":"2024-08-30","current":-3.655014,"twenty":-4.050383,"median":-3.84693,"eighty":-3.659692,"marketCap":690921935},{"date":"2024-09-06","current":-3.442045,"twenty":-4.027205,"median":-3.798947,"eighty":-3.608967,"marketCap":650663491},{"date":"2024-09-13","current":-3.33556,"twenty":-4.023985,"median":-3.741353,"eighty":-3.511116,"marketCap":630534270},{"date":"2024-09-20","current":-3.301025,"twenty":-4.023985,"median":-3.709695,"eighty":-3.405847,"marketCap":624005873},{"date":"2024-09-27","current":-3.211808,"twenty":-3.980142,"median":-3.685233,"eighty":-3.395997,"marketCap":607140850},{"date":"2024-10-04","current":-2.803137,"twenty":-3.959602,"median":-3.672282,"eighty":-3.303903,"marketCap":529888161},{"date":"2024-10-11","current":-2.978693,"twenty":-3.946725,"median":-3.656453,"eighty":-3.263611,"marketCap":563074175},{"date":"2024-10-18","current":-3.462191,"twenty":-3.930629,"median":-3.608967,"eighty":-3.220442,"marketCap":654471723},{"date":"2024-10-25","current":-3.424777,"twenty":-3.915649,"median":-3.608753,"eighty":-3.22332,"marketCap":647399293},{"date":"2024-11-01","current":-3.254977,"twenty":-3.914533,"median":-3.516406,"eighty":-3.231953,"marketCap":615301345},{"date":"2024-11-08","current":-3.459313,"twenty":-3.86344,"median":-3.50536,"eighty":-3.240587,"marketCap":653927690},{"date":"2024-11-15","current":-2.016571,"twenty":-3.859807,"median":-3.465068,"eighty":-3.22332,"marketCap":481504843},{"date":"2024-11-22","current":-2.155567,"twenty":-3.851156,"median":-3.454996,"eighty":-3.18015,"marketCap":514693313},{"date":"2024-11-29","current":-2.109995,"twenty":-3.85035,"median":-3.444923,"eighty":-3.067334,"marketCap":503811848},{"date":"2024-12-06","current":-2.050751,"twenty":-3.847574,"median":-3.439167,"eighty":-2.978693,"marketCap":489665943},{"date":"2024-12-13","current":-1.911755,"twenty":-3.823752,"median":-3.419021,"eighty":-2.94646,"marketCap":456477473},{"date":"2024-12-20","current":-2.009736,"twenty":-3.802749,"median":-3.405847,"eighty":-2.329653,"marketCap":479872624},{"date":"2024-12-27","current":-1.836561,"twenty":-3.764391,"median":-3.395997,"eighty":-2.153744,"marketCap":438523055},{"date":"2025-01-03","current":-1.925427,"twenty":-3.741353,"median":-3.367218,"eighty":-2.142807,"marketCap":459741913},{"date":"2025-01-10","current":-1.595028,"twenty":-3.741353,"median":-3.312536,"eighty":-2.023407,"marketCap":380851289},{"date":"2025-01-17","current":-1.745417,"twenty":-3.740777,"median":-3.298147,"eighty":-1.989684,"marketCap":416760124},{"date":"2025-01-24","current":-1.522113,"twenty":-3.738475,"median":-3.27944,"eighty":-1.964163,"marketCap":363440944},{"date":"2025-01-31","current":-1.704402,"twenty":-3.735597,"median":-3.263611,"eighty":-1.93682,"marketCap":406966805},{"date":"2025-02-07","current":-1.291973,"twenty":-3.709695,"median":-3.247782,"eighty":-1.911755,"marketCap":308489544},{"date":"2025-02-14","current":-1.187157,"twenty":-3.703939,"median":-3.22332,"eighty":-1.873019,"marketCap":283462173},{"date":"2025-02-21","current":-1.178042,"twenty":-3.690125,"median":-3.211808,"eighty":-1.829725,"marketCap":281285880},{"date":"2025-02-28","current":-1.059555,"twenty":-3.68437,"median":-3.162882,"eighty":-1.759544,"marketCap":252994070},{"date":"2025-03-07","current":-1.111963,"twenty":-3.676887,"median":-3.070787,"eighty":-1.711693,"marketCap":265507755},{"date":"2025-03-14","current":-1.041326,"twenty":-3.672858,"median":-3.006033,"eighty":-1.678881,"marketCap":248641484},{"date":"2025-03-21","current":-0.693421,"twenty":-3.667968,"median":-2.978693,"eighty":-1.565406,"marketCap":204027476},{"date":"2025-03-28","current":-1.042906,"twenty":-3.659692,"median":-2.965742,"eighty":-1.505251,"marketCap":306857324},{"date":"2025-04-04","current":-1.85837,"twenty":-3.65559,"median":-2.803137,"eighty":-1.500694,"marketCap":546793636},{"date":"2025-04-11","current":-1.198232,"twenty":-3.63199,"median":-2.286587,"eighty":-1.463027,"marketCap":352559478},{"date":"2025-04-17","current":-0.924562,"twenty":-3.622781,"median":-2.176074,"eighty":-1.280365,"marketCap":272036635},{"date":"2025-04-25","current":-0.791425,"twenty":-3.613572,"median":-2.146452,"eighty":-1.183511,"marketCap":232863359},{"date":"2025-05-02","current":-0.848748,"twenty":-3.60871,"median":-2.125945,"eighty":-1.162092,"marketCap":249729630},{"date":"2025-05-09","current":-0.930109,"twenty":-3.590112,"median":-2.016571,"eighty":-1.140673,"marketCap":273668854},{"date":"2025-05-16","current":-0.890525,"twenty":-3.561975,"median":-1.997203,"eighty":-1.105127,"marketCap":305759157},{"date":"2025-05-23","current":-0.766929,"twenty":-3.530406,"median":-1.968721,"eighty":-1.070948,"marketCap":263322832},{"date":"2025-05-30","current":-0.619565,"twenty":-3.51429,"median":-1.964163,"eighty":-1.045883,"marketCap":212725677},{"date":"2025-06-06","current":-0.530829,"twenty":-3.506511,"median":-1.95277,"eighty":-1.037224,"marketCap":182258572},{"date":"2025-06-13","current":-0.503891,"twenty":-3.48667,"median":-1.925427,"eighty":-0.984896,"marketCap":173009629},{"date":"2025-06-20","current":-0.476954,"twenty":-3.466829,"median":-1.916313,"eighty":-0.943233,"marketCap":163760687},{"date":"2025-06-27","current":-0.522906,"twenty":-3.464493,"median":-1.909477,"eighty":-0.920124,"marketCap":179538295}],"updateTime":1751250424280}}}